Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extrahepatic Bile Duct Adenocarcinoma”

96 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 96 results

Large-scale testing (Phase 3)Study completedNCT01313377
What this trial is testing

Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
UNICANCER 190
Large-scale testing (Phase 3)Ended earlyNCT04163900
What this trial is testing

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
NuCana plc 773
Early research (Phase 1)Study completedNCT00486356
What this trial is testing

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more
University of Nebraska 46
Not applicableLooking for participantsNCT07007832
What this trial is testing

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Who this might be right for
CholangiocarcinomaGallbladder Cancer and Extrahepatic CholangiocarcinomaPancreatic Cancer+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 818
Not applicableLooking for participantsNCT05519319
What this trial is testing

Safety and Efficacy of PDT vs RFA vs PDT+RFA for the Treatment of Extrahepatic Cholangiocarcinoma

Who this might be right for
Extrahepatic CholangiocarcinomaBile Duct Cancer
First People's Hospital of Hangzhou 70
Testing effectiveness (Phase 2)Study completedNCT00553332
What this trial is testing

Selumetinib in Treating Patients With Biliary Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver and Intrahepatic Biliary Tract CancerRecurrent Extrahepatic Bile Duct CancerUnresectable Extrahepatic Bile Duct Cancer
National Cancer Institute (NCI) 29
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Ended earlyNCT00005997
What this trial is testing

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Case Comprehensive Cancer Center 72
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT00023946
What this trial is testing

BMS-247550 in Treating Patients With Liver or Gallbladder Cancer

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Ended earlyNCT00658593
What this trial is testing

Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
NCIC Clinical Trials Group 19
Testing effectiveness (Phase 2)Study completedNCT01954745
What this trial is testing

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Who this might be right for
Bile Duct CancerIntrahepatic CholangiocarcinomaCholangiocarcinoma of the Extrahepatic Bile Duct
Massachusetts General Hospital 19
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Testing effectiveness (Phase 2)UnknownNCT00003296
What this trial is testing

Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder CancerLiver Cancer
Brown University 26
Early research (Phase 1)Study completedNCT00066404
What this trial is testing

Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions

Who this might be right for
Cancer
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00753675
What this trial is testing

Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerGallbladder CancerCancer Of The Extrahepatic Bile Duct+1 more
Genzyme, a Sanofi Company 174
Load More Results